| Literature DB >> 33800819 |
Céline Moriou1, Damien Lacroix1, Sylvain Petek2, Amr El-Demerdash1, Rozenn Trepos2, Tinihauarii Mareva Leu3, Cristina Florean4, Marc Diederich5, Claire Hellio2, Cécile Debitus2, Ali Al-Mourabit1.
Abstract
Chemical investigation of the South-Pacific marine sponge Suberea clavata led to the isolation of eight new bromotyrosine metabolites named subereins 1-8 (2-9) along with twelve known co-isolated congeners. The detailed configuration determination of the first representative major compound of this family 11-epi-fistularin-3 (11R,17S) (1) is described. Their chemical characterization was achieved by HRMS and integrated 1D and 2D NMR (nuclear magnetic resonance) spectroscopic studies and extensive comparison with literature data. For the first time, a complete assignment of the absolute configurations for stereogenic centers C-11/17 of the known members (11R,17S) 11-epi-fistularin-3 (1) and 17-deoxyfistularin-3 (10) was determined by a combination of chemical modifications, Mosher's technology, and ECD spectroscopy. Consequently, the absolute configurations of all our new isolated compounds 2-9 were determined by the combination of NMR, Mosher's method, ECD comparison, and chemical modifications. Interestingly, compounds 2-7 were obtained by chemical transformation of the major compound 11-epi-fistularin-3 (1). Evaluation for acetylcholinesterase inhibition (AChE), DNA methyltransferase 1 (DNMT1) modulating activity and antifouling activities using marine bacterial strains are also presented.Entities:
Keywords: Suberea clavata; Verongiida; acetylcholinesterase inhibition; antifouling; bromotyrosine; fistularin-3; sponge
Year: 2021 PMID: 33800819 PMCID: PMC7999702 DOI: 10.3390/md19030143
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118